Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Arrhythmias

Free Subscription Articles published in J Cardiovasc Pharmacol Retrieve available abstracts of 27 articles: HTML format

Single Articles

June 2026
1. HAMZAH KA, Kurmasha YH, Rasheed WM, Al-Shammari AS, et al
   Ivabradine in Heart Transplant Recipients With Sinus Tachycardia: A Systematic Review and Meta-Analysis.
   J Cardiovasc Pharmacol. 2026 Jun 4. doi: 10.1097/FJC.0000000000001840.
   PubMed     Abstract available
   
   
   April 2026
2. SMAJIC E, Jahic E, Mrsic D, Berberovic-Hukeljic B, et al
   Rivaroxaban safety and adherence in patients with nonvalvular atrial fibrillation: prospective, observational, cohort, postmarketing study.
   J Cardiovasc Pharmacol. 2026 Apr 21. doi: 10.1097/FJC.0000000000001829.
   PubMed     Abstract available
   
   
   
3. GAO P, Wang W, Wang W, Liu M, et al
   Sonodynamic Therapy Attenuates TLR4/NF-kappaB Signaling in Epicardial Adipose Tissue of Atrial Fibrillation: Insights from Animal Models, scRNA-seq, and Mendelian Randomization.
   J Cardiovasc Pharmacol. 2026 Apr 9. doi: 10.1097/FJC.0000000000001825.
   PubMed     Abstract available
   
   
   December 2025
4. BARBOSA LM, Rodrigues Oliveira VM, Nunes MDCP, Moreira HG, et al
   Direct Oral Anticoagulants versus Warfarin on Coronary Plaque in Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
   J Cardiovasc Pharmacol. 2025 Dec 16. doi: 10.1097/FJC.0000000000001787.
   PubMed     Abstract available
   
   
   October 2025
5. TISDALE JE, Jaynes HA, Overholser BR, Sowinski KM, et al
   Dihydrotestosterone Pretreatment Diminishes the Severity of Drug-Induced Torsades de Pointes.
   J Cardiovasc Pharmacol. 2025;86:343-349.
   PubMed     Abstract available
   
   
   September 2025
6. GIULIANA C, Filomia S, Ricci M, Pinnacchio G, et al
   Treating the Broken Heart: Role of Stellate Ganglion Blockade in Takotsubo Syndrome.
   J Cardiovasc Pharmacol. 2025;86:234-238.
   PubMed     Abstract available
   
   
   July 2025
7. AVE MT, Brion M, Blanco-Verea A, Gil A, et al
   Relevance of CYP2D6 in the Efficacy and Toxicity of Flecainide in Patients with Atrial Fibrillation: A Cohort Study.
   J Cardiovasc Pharmacol. 2025 Jul 24. doi: 10.1097/FJC.0000000000001739.
   PubMed     Abstract available
   
   
   
8. FAGHIHI M, Ahmadi-Beni M, Houshmand F
   Role of Muscarinic Acetylcholine Receptors in Oxytocin-Induced Cardioprotection Against Ischemia-Reperfusion Injury in Rats.
   J Cardiovasc Pharmacol. 2025;86:109-117.
   PubMed     Abstract available
   
   
   May 2025
9. ATMACA H, Yetkin E
   Coupling Interval Ratio to Predict the Beta-Blocker Response Against Premature Ventricular Complexes.
   J Cardiovasc Pharmacol. 2025;85:364-368.
   PubMed     Abstract available
   
   
   March 2025
10. SAMOS M, Skerenova M, Nosal V, Skornova I, et al
    ABCB1 gene single nucleotide variants and haplotypes in atrial fibrillation patients experiencing adverse events on direct oral anticoagulation: a whole gene exome sequencing study.
    J Cardiovasc Pharmacol. 2025 Mar 28. doi: 10.1097/FJC.0000000000001695.
    PubMed     Abstract available
    
    
    
11. AHUJA T, Saadi R, Papadopoulos J, Bernard S, et al
    Digoxin Loading Doses and Serum Digoxin Concentrations for Rate Control of Atrial Arrhythmias in Critically Ill Patients.
    J Cardiovasc Pharmacol. 2025;85:211-216.
    PubMed     Abstract available
    
    
    January 2025
12. ZHANG X, Liu J, Shi Y, Wang H, et al
    Effect of different doses of dexmedetomidine on atrial fibrillation in adults after cardiac surgery.
    J Cardiovasc Pharmacol. 2025 Jan 23. doi: 10.1097/FJC.0000000000001674.
    PubMed     Abstract available
    
    
    December 2024
13. HAKGOR A, Olgun FE, Dursun A, Kahraman BC, et al
    Sodium glucose cotransporter 2 inhibitors improve long-term atrial fibrillation-free survival after catheter ablation.
    J Cardiovasc Pharmacol. 2024 Dec 31. doi: 10.1097/FJC.0000000000001656.
    PubMed     Abstract available
    
    
    November 2024
14. SCHULZ C, Eschenhagen T, Christ T
    Atrial hiPSC-CM as a Pharmacologic Model to Evaluate Anti-AF Drugs: Some Lessons From I Kur.
    J Cardiovasc Pharmacol. 2024;84:479-485.
    PubMed     Abstract available
    
    
    October 2024
15. DAKROUB A, Beaini H, Kibbi R, Moumneh MB, et al
    Comparative Analysis of Anticoagulation Versus Combination Anticoagulation and Antiplatelet Therapy in Atrial Fibrillation Patients Presenting With Gastrointestinal Bleeding.
    J Cardiovasc Pharmacol. 2024 Oct 10. doi: 10.1097/FJC.0000000000001641.
    PubMed     Abstract available
    
    
    September 2024
16. ISMAILI D, Petersen J, Schulz C, Eschenhagen T, et al
    PDE8 Inhibition and Its Impact on ICa,L in Persistent Atrial Fibrillation: Evaluation of PDE8 as a Potential Drug Target.
    J Cardiovasc Pharmacol. 2024 Sep 13. doi: 10.1097/FJC.0000000000001630.
    PubMed     Abstract available
    
    
    August 2024
17. WU L, Li Z, Xu L, Fan Y, et al
    Nrf2 ameliorates atrial fibrosis during antithrombotic therapy for atrial fibrillation by modulating CYP2C9 activity.
    J Cardiovasc Pharmacol. 2024 Aug 12. doi: 10.1097/FJC.0000000000001618.
    PubMed     Abstract available
    
    
    
18. ZOU Y, Liu X, Hu Y, Zhang C, et al
    Inhibition of alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors Ameliorates Atrial Inflammation and Vulnerability to Atrial Fibrillation in Rats with Anxiety Disorders.
    J Cardiovasc Pharmacol. 2024;84:227-238.
    PubMed     Abstract available
    
    
    
19. GOLINO M, Lazzerini PE
    Hydroxychloroquine, Chloroquine, and Arrhythmic Risk in Systemic Autoimmune Diseases: Focus More on the Patient and You Will Keep the Rhythm!
    J Cardiovasc Pharmacol. 2024;84:149-151.
    PubMed    
    
    
    
20. NIKOLIC RPA, Virk MK, Buhler KA, Costenbader KH, et al
    Hydroxychloroquine and Chloroquine-Induced Cardiac Arrhythmias and Sudden Cardiac Death in Patients With Systemic Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis.
    J Cardiovasc Pharmacol. 2024;84:158-169.
    PubMed     Abstract available
    
    
    July 2024
21. BURASHNIKOV A, Antzelevitch C
    The efficacy of INa block to cardiovert atrial fibrillation is enhanced by inhibition of IK1.
    J Cardiovasc Pharmacol. 2024 Jul 29. doi: 10.1097/FJC.0000000000001617.
    PubMed     Abstract available
    
    
    
22. ZHANG J, Xiong X, Li J, Luo C, et al
    Valtrate suppresses TNFSF14-mediated arrhythmia after myocardial ischemia-reperfusion via inducing N-linked glycosylation of LTbetaR to regulate MGA/MAX/c-Myc/Cx43.
    J Cardiovasc Pharmacol. 2024 Jul 19. doi: 10.1097/FJC.0000000000001613.
    PubMed     Abstract available
    
    
    March 2024
23. CHEN YF, Liu NN, Wang JY, Sun JS, et al
    Use of 3D echocardiography facilitates analysis of thrombolytic efficacy in patients with persistent atrial fibrillation.
    J Cardiovasc Pharmacol. 2024 Mar 25. doi: 10.1097/FJC.0000000000001567.
    PubMed     Abstract available
    
    
    December 2023
24. RIVERA FB, Cha SW, Aparece JP, Jariyatamkitti S, et al
    Efficacy and safety of colchicine for the prevention of postoperative atrial fibrillation among patients undergoing major cardiothoracic surgery: a meta-analysis and meta-regression of randomized controlled trials.
    J Cardiovasc Pharmacol. 2023 Dec 28. doi: 10.1097/FJC.0000000000001533.
    PubMed     Abstract available
    
    
    
25. SPADAFORA L, Gaudio C, Biondi-Zoccai G, Frati G, et al
    Catalysts of cardiovascular electromechanical harmony? Unveiling the impact of RAS Inhibitors and ARNI on atrial fibrillation recurrence after ablation.
    J Cardiovasc Pharmacol. 2023 Dec 27. doi: 10.1097/FJC.0000000000001537.
    PubMed    
    
    
    November 2023
26. SUN Q, Cui W, Zhang X, Tian Y, et al
    A Systematic Review and Meta-analysis of Renin-angiotensin Inhibitors and Angiotensin Receptor Neprilysin Inhibitors in Preventing Recurrence after Atrial Fibrillation Ablation.
    J Cardiovasc Pharmacol. 2023 Nov 22. doi: 10.1097/FJC.0000000000001517.
    PubMed     Abstract available
    
    
    September 2023
27. AMARH E, Tisdale JE, Overholser BR
    Prolonged Exposure to Remdesivir Inhibits the Human Ether-A-Go-Go-Related Gene Potassium Current.
    J Cardiovasc Pharmacol. 2023;82:212-220.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum